- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/08 - AntiepilepticsAnticonvulsants
Patent holdings for IPC class A61P 25/08
Total number of patents in this class: 2681
10-year publication summary
|
72
|
68
|
125
|
197
|
180
|
213
|
249
|
200
|
181
|
182
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| GW Research Limited | 195 |
108 |
| Jazz Pharmaceuticals Research UK Limited | 219 |
66 |
| Xenon Pharmaceuticals Inc. | 190 |
44 |
| Taisho Pharmaceutical Co., Ltd. | 865 |
43 |
| The Regents of the University of California | 20137 |
39 |
| Sage Therapeutics, Inc. | 368 |
34 |
| Takeda Pharmaceutical Company Limited | 2706 |
32 |
| Zogenix International Limited | 76 |
30 |
| Katholieke Universiteit Leuven | 1200 |
27 |
| Praxis Precision Medicines, Inc. | 179 |
26 |
| Institute of Materia Medica, Chinese Academy of Medical Sciences | 180 |
25 |
| Hoffmann-La Roche Inc. | 3484 |
24 |
| F. Hoffmann-La Roche AG | 7947 |
23 |
| Janssen Pharmaceutica N.V. | 3370 |
23 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3368 |
20 |
| Centre National de La Recherche Scientifique | 10576 |
17 |
| The Johns Hopkins University | 5723 |
17 |
| Sumitomo Dainippon Pharma Co., Ltd. | 212 |
16 |
| Eisai R&D Management Co., Ltd. | 1222 |
15 |
| Daiichi Sankyo Company, Limited | 1875 |
14 |
| Other owners | 2038 |